Day 2 - Friday 5th May 2023
9th Market Access, Pricing & Reimbursement Global Congress 2023 Europe
Trends and Strategies to Achieve Optimum Patient Access to Healthcare
CHALLENGES & OPPORTUNITIES
- Advantages of market access teams in payer relationship
- Payer evidence requirement in early development
- Best practices to obtain better pricing and reimbursement
- Strategies to improve a better payer relationship
Claudia Neuber, Head, Global Pricing Oncology, Global Market Access & Pricing, AstraZeneca
- Why is this important?
- Current state of play
- Barriers to Equity Pricing
- Potential solutions and some principles to maximize impact of Equity Pricing
- Innovative approaches required to address the medicine access challenge
- Lessons to be learned from best practices in the field of pricing and reimbursement of medicines
- The value of list prices against the backdrop of external price referencing and managed entry agreements.
- Innovative policy options that needs to be developed, agreed upon and implemented.
- Keeping on top of pricing and market access trends
- Identify a clinical or economic advantage and generate the appropriate clinical and health economic evidence to support a strong value proposition
- Optimising the use of Patient-Reported Outcomes
- Unlocking data from early access
- Effective communications with internal and external stakeholders
- Embracing the digital vision
- Challenges in drug pricing and reimbursement
- How to navigate a complex balance between financial and strategic risks
- Strategies to offset regulatory and inflationary pressures.
- Addressing environmental, social, and corporate governance issues
- Encouraging cross-functional or cross-company collaborations
- The increasing relevance of Emerging Markets
- EMs Embrace Technological Innovation
- Creating value through partnership
- How to Avoid the Pitfalls of Innovation in Emerging Markets
- Objective: Activating the full stakeholder ecosystem to shift conversation from price to value to get access to innovative therapies
- Why is the full stakeholder ecosystem important for gaining access in the future?
- How to Identify the stakeholder ecosystem for access success
- Step by step: Setting up a cross-functional program for access success
- Assessment of financial benefit from tendering
- Evaluating its impact on prices and market concentration
- Consideration of its operational framework
- Tendering for pharmaceuticals as a reimbursement tool
- The importance of making MA the core of the company
- Bridge between pre-launch strategy and post-launch
- International Drug Price Indicator Guide WHO
- Increasing collaboration between EU countries
- Frontiers in Health Care
- What will the future bring?
